Fingerprint
Dive into the research topics of 'Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC
Steven H. Lin, Yan Lin, Luyang Yao, Neda Kalhor, Brett W. Carter, Mehmet Altan, George Blumenschein, Lauren A. Byers, Frank Fossella, Don L. Gibbons, Jonathan M. Kurie, Charles Lu, George Simon, Ferdinandos Skoulidis, Joe Y. Chang, Melenda D. Jeter, Zhongxing Liao, Daniel R. Gomez, Michael O'Reilly, Vali Papadimitrakopoulou
Research output: Contribution to journal › Article › peer-review
92
Scopus
citations